MYOVANT SCIENCES LTD. Indemnification AgreementIndemnification Agreement • September 30th, 2016 • Myovant Sciences Ltd. • Pharmaceutical preparations
Contract Type FiledSeptember 30th, 2016 Company IndustryThis INDEMNIFICATION AGREEMENT, dated and effective as of (this “Agreement”), is by and between MYOVANT SCIENCES LTD., an exempted limited company incorporated under the laws of Bermuda (the “Company” (as such definition is further expanded below)) , and, if such individual is a Director serving the Company as a representative of an entity, (each an “Indemnitee” and collectively, the “Indemnitees”).
AXOVANT SCIENCES LTD. INDEMNIFICATION AGREEMENTIndemnification Agreement • May 22nd, 2015 • Axovant Sciences Ltd. • Pharmaceutical preparations
Contract Type FiledMay 22nd, 2015 Company IndustryThis INDEMNIFICATION AGREEMENT, dated and effective as of (this “Agreement”), is by and between AXOVANT SCIENCES LTD., an exempted limited company incorporated under the laws of Bermuda (the “Company” (as such definition is further expanded below)) , and, if such individual is a Director serving the Company as a representative of an entity, (each an “Indemnitee” and collectively, the “Indemnitees”).
KEMPHARM, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • December 19th, 2014 • Kempharm, Inc • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 19th, 2014 Company Industry JurisdictionThis INDEMNIFICATION AGREEMENT, dated and effective as of (this “Agreement”), is by and between KEMPHARM, INC., a Delaware corporation (the “Company” (as such definition is further expanded below)), , and, if such individual is a Director serving the Company as a representative of an entity, (each an “Indemnitee” and collectively, the “Indemnitees”).
GLYCOMIMETICS, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • October 28th, 2013 • Glycomimetics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 28th, 2013 Company Industry JurisdictionThis INDEMNIFICATION AGREEMENT, dated and effective as of (this “Agreement”), is by and between GLYCOMIMETICS, INC., a Delaware corporation (the “Company” (as such definition is further expanded below)), , and, if such individual is a Director serving the Company as a representative of an entity, (each an “Indemnitee” and collectively, the “Indemnitees”).